
1. parasitol res. 2013 may;112(5):1959-66. doi: 10.1007/s00436-013-3352-0. epub 2013
feb 28.

the specific, reversible jnk inhibitor sp600125 improves survivability and
attenuates neuronal cell death experimental cerebral malaria (ecm).

anand ss(1), maruthi m, babu pp.

author information: 
(1)department biotechnology, school life sciences, university hyderabad,
gachibowli, hyderabad, 500 046, india.

cerebral malaria (cm) severe complication plasmodium falciparum in
humans major cause death. sp600125 specific, small molecule inhibitor
of jnk prevents phosphorylation c-jun blocks expression of
proinflammatory cytokines attenuates neuronal apoptosis several
neurodegenerative disorders. evaluated effect sp600125 treatment the
survival plasmodium berghei anka (pba)-infected c57bl/6j mice. administration 
of sp600125 improved survival pba-infected c57bl6j mice effect on
parasitemia. further, sp600125 administration resulted attenuation neuronal
cell death along inhibition proinflammatory mediators tnf-Î± cox-2 and
proapoptotic mediators p-c-jun active caspase 3 pba-infected mice. the
promising findings study make sp600125 potential agent supportive
therapy alleviate inflammation neuronal cell death associated cm.

doi: 10.1007/s00436-013-3352-0 
pmid: 23455938  [indexed medline]

